메뉴 건너뛰기




Volumn 138, Issue 6, 2016, Pages 1506-1515

The influence of hormone therapies on type i and II endometrial cancer: A nationwide cohort study

Author keywords

endometrial cancer; hormone therapy; types of endometrial cancer; types of hormone replacement therapy

Indexed keywords

CONJUGATED ESTROGEN; CYPROTERONE ACETATE; ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE; NORETHISTERONE ACETATE; RALOXIFENE; TIBOLONE;

EID: 84954186628     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29878     Document Type: Article
Times cited : (51)

References (31)
  • 1
    • 0028809308 scopus 로고
    • Hormone replacement therapy and endometrial cancer risk: A meta-analysis
    • Grady D, Gebretsadik T, Kerlikowske K, et al., Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995; 85: 304-13.
    • (1995) Obstet Gynecol , vol.85 , pp. 304-313
    • Grady, D.1    Gebretsadik, T.2    Kerlikowske, K.3
  • 2
    • 84869503034 scopus 로고    scopus 로고
    • Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
    • Trabert B, Wentzensen N, Yang HP, et al., Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer 2013; 132: 417-26.
    • (2013) Int J Cancer , vol.132 , pp. 417-426
    • Trabert, B.1    Wentzensen, N.2    Yang, H.P.3
  • 3
    • 18144421167 scopus 로고    scopus 로고
    • Endometrial cancer and hormone-replacement therapy in the Million Women Study
    • Beral V, Bull D, Reeves G, et al., Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005; 365: 1543-51.
    • (2005) Lancet , vol.365 , pp. 1543-1551
    • Beral, V.1    Bull, D.2    Reeves, G.3
  • 4
    • 84899917635 scopus 로고    scopus 로고
    • Menopausal hormone therapy and risk of endometrial cancer
    • Brinton LA, Felix AS., Menopausal hormone therapy and risk of endometrial cancer. J Steroid Biochem Mol Biol 2014; 142: 83-9.
    • (2014) J Steroid Biochem Mol Biol , vol.142 , pp. 83-89
    • Brinton, L.A.1    Felix, A.S.2
  • 5
    • 79952115034 scopus 로고    scopus 로고
    • Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into cancer and nutrition
    • Allen NE, Tsilidis KK, Key TJ, et al., Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into cancer and nutrition. Am J Epidemiol 2010; 172: 1394-403.
    • (2010) Am J Epidemiol , vol.172 , pp. 1394-1403
    • Allen, N.E.1    Tsilidis, K.K.2    Key, T.J.3
  • 6
    • 0030862208 scopus 로고    scopus 로고
    • Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas
    • Sherman ME, Sturgeon S, Brinton LA, et al., Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol 1997; 10: 963-8.
    • (1997) Mod Pathol , vol.10 , pp. 963-968
    • Sherman, M.E.1    Sturgeon, S.2    Brinton, L.A.3
  • 7
    • 0034083599 scopus 로고    scopus 로고
    • Theories of endometrial cancer carcinogenesis: A multidisciplinary approach
    • Sherman ME., Theories of endometrial cancer carcinogenesis: a multidisciplinary approach. Mod Pathol 2000; 13: 295-308.
    • (2000) Mod Pathol , vol.13 , pp. 295-308
    • Sherman, M.E.1
  • 8
    • 84872225562 scopus 로고    scopus 로고
    • Endometrial cancer risk factors by 2 main histologic subtypes. the NIH-AARP diet and health study
    • Yang HP, Wentzensen N, Trabert B, et al., Endometrial cancer risk factors by 2 main histologic subtypes. The NIH-AARP diet and health study. Am J Epidemiol 2013; 177: 142-51.
    • (2013) Am J Epidemiol , vol.177 , pp. 142-151
    • Yang, H.P.1    Wentzensen, N.2    Trabert, B.3
  • 9
    • 67651030608 scopus 로고    scopus 로고
    • Hormone therapy and ovarian cancer
    • Mørch LS, Løkkegaard E, Andreasen AH, et al., Hormone therapy and ovarian cancer. JAMA 2009; 302: 298-305.
    • (2009) JAMA , vol.302 , pp. 298-305
    • Mørch, L.S.1    Løkkegaard, E.2    Andreasen, A.H.3
  • 11
    • 42149136283 scopus 로고    scopus 로고
    • Using prescription registries to define continuous drug use: How to fill gaps between prescriptions
    • Nielsen LH, Løkkegaard E, Andreasen AH, et al., Using prescription registries to define continuous drug use: how to fill gaps between prescriptions. Pharmacoepidemiol Drug Saf 2008; 17: 384-8.
    • (2008) Pharmacoepidemiol Drug Saf , vol.17 , pp. 384-388
    • Nielsen, L.H.1    Løkkegaard, E.2    Andreasen, A.H.3
  • 12
    • 78449286682 scopus 로고    scopus 로고
    • Factors associated with type i and type II endometrial cancer
    • Felix AS, Weissfeld JL, Stone RA, et al., Factors associated with type I and type II endometrial cancer. Cancer Causes Control 2010; 21: 1851-6.
    • (2010) Cancer Causes Control , vol.21 , pp. 1851-1856
    • Felix, A.S.1    Weissfeld, J.L.2    Stone, R.A.3
  • 13
    • 3042811414 scopus 로고    scopus 로고
    • Prognostic parameters of endometrial carcinoma
    • Prat J., Prognostic parameters of endometrial carcinoma. Hum Pathol 2004; 35: 649-62.
    • (2004) Hum Pathol , vol.35 , pp. 649-662
    • Prat, J.1
  • 16
    • 0029089461 scopus 로고
    • Applying Cox regression to competing risks
    • Lunn M, McNeil D., Applying Cox regression to competing risks. Biometrics 1995; 51: 524-32.
    • (1995) Biometrics , vol.51 , pp. 524-532
    • Lunn, M.1    McNeil, D.2
  • 17
    • 0027159206 scopus 로고
    • Joint analysis of site-specific cancer risks for the atomic bomb survivors
    • Pierce DA, Preston DL., Joint analysis of site-specific cancer risks for the atomic bomb survivors. Radiat Res 1993; 134: 134-42.
    • (1993) Radiat Res , vol.134 , pp. 134-142
    • Pierce, D.A.1    Preston, D.L.2
  • 18
    • 0020660717 scopus 로고
    • Two pathogenetic types of endometrial carcinoma
    • Bokhman JV., Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983; 15: 10-17.
    • (1983) Gynecol Oncol , vol.15 , pp. 10-17
    • Bokhman, J.V.1
  • 19
    • 84883854572 scopus 로고    scopus 로고
    • Type i and II endometrial cancers: Have they different risk factors?
    • Setiawan VW, Yang HP, Pike MC, et al., Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013; 31: 2607-18.
    • (2013) J Clin Oncol , vol.31 , pp. 2607-2618
    • Setiawan, V.W.1    Yang, H.P.2    Pike, M.C.3
  • 20
    • 84906937868 scopus 로고    scopus 로고
    • Why the product labeling on low dose vaginal estrogen should be changed
    • 1 6
    • Manson JE, Goldstein SR, Kagan R, et al., Why the product labeling on low dose vaginal estrogen should be changed. Menopause 2014; 21: 911 -1 6.
    • (2014) Menopause , vol.21 , pp. 911
    • Manson, J.E.1    Goldstein, S.R.2    Kagan, R.3
  • 21
    • 73349103184 scopus 로고    scopus 로고
    • Endometrial cancer in postmenopausal women using estrogen-progestin therapy
    • Jaakkola S, Lyytinen H, Pukkala E, et al., Endometrial cancer in postmenopausal women using estrogen-progestin therapy. Obstet Gynaecol 2009; 114: 1197-204.
    • (2009) Obstet Gynaecol , vol.114 , pp. 1197-1204
    • Jaakkola, S.1    Lyytinen, H.2    Pukkala, E.3
  • 22
    • 79551484149 scopus 로고    scopus 로고
    • Endometrial cancer associated with various forms of postmenopausal hormone therapy: A case control study
    • Jaakkola S, Lyytinen HK, Dyba T, et al., Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study. In J Cancer 2011; 128: 1644-51.
    • (2011) In J Cancer , vol.128 , pp. 1644-1651
    • Jaakkola, S.1    Lyytinen, H.K.2    Dyba, T.3
  • 23
    • 33947506942 scopus 로고    scopus 로고
    • Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AAA Diet and Health Study
    • Lacey JV, Leitzmann MF, Chang SC, et al., Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AAA Diet and Health Study. Cancer 2007; 109: 1303-11.
    • (2007) Cancer , vol.109 , pp. 1303-1311
    • Lacey, J.V.1    Leitzmann, M.F.2    Chang, S.C.3
  • 24
    • 22244447072 scopus 로고    scopus 로고
    • Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women
    • Lacey JV, Brinton LA, Lubin JH, et al., Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005; 14: 1724-31.
    • (2005) Cancer Epidemiol Biomarkers Prev , vol.14 , pp. 1724-1731
    • Lacey, J.V.1    Brinton, L.A.2    Lubin, J.H.3
  • 25
    • 0023934696 scopus 로고
    • Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures
    • Storm HH., Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol 1988; 17: 44-9.
    • (1988) Int J Epidemiol , vol.17 , pp. 44-49
    • Storm, H.H.1
  • 26
    • 0030678495 scopus 로고    scopus 로고
    • The Danish cancer register - History, content, quality, and use
    • Storm HH, Michelsen EV, Clemmensen IH, et al., The Danish cancer register-history, content, quality, and use. Dan Med Bull 1997; 44: 535-9.
    • (1997) Dan Med Bull , vol.44 , pp. 535-539
    • Storm, H.H.1    Michelsen, E.V.2    Clemmensen, I.H.3
  • 27
    • 0036685874 scopus 로고    scopus 로고
    • Validity of breast cancer in the Danish cancer register. A study based on clinical records from one county in Denmark
    • Jensen AR, Overgaard J, Storm HH., Validity of breast cancer in the Danish cancer register. A study based on clinical records from one county in Denmark. Eur J Cancer Prev 2002; 11: 359-64.
    • (2002) Eur J Cancer Prev , vol.11 , pp. 359-364
    • Jensen, A.R.1    Overgaard, J.2    Storm, H.H.3
  • 28
    • 77956978331 scopus 로고    scopus 로고
    • Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort
    • Canchola AJ, Chang ET, Bernstein L, et al., Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort. Cancer Causes Control 2010; 21: 1407-16.
    • (2010) Cancer Causes Control , vol.21 , pp. 1407-1416
    • Canchola, A.J.1    Chang, E.T.2    Bernstein, L.3
  • 29
    • 0033993892 scopus 로고    scopus 로고
    • Use of hormone replacement therapy among Danish nurses in 1993
    • Hundrup YA, Obel EB, Rasmussen NK, et al., Use of hormone replacement therapy among Danish nurses in 1993. Actra Obstet Gynecol Scand 2000; 79: 194-201.
    • (2000) Actra Obstet Gynecol Scand , vol.79 , pp. 194-201
    • Hundrup, Y.A.1    Obel, E.B.2    Rasmussen, N.K.3
  • 30
    • 0037541419 scopus 로고    scopus 로고
    • Age at natural menopause and all-cause mortality: A 37-year follow-up of 19,731 Norwegian women
    • Jacobsen BK, Heuch I, Kvåle G., Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003; 157: 923-9.
    • (2003) Am J Epidemiol , vol.157 , pp. 923-929
    • Jacobsen, B.K.1    Heuch, I.2    Kvåle, G.3
  • 31
    • 0030296073 scopus 로고    scopus 로고
    • Hormone replacement therapy and previous use of oral contraceptives among Swedish women
    • Hammer M, Brynhildsen Dabrosin L, Frisk J, et al., Hormone replacement therapy and previous use of oral contraceptives among Swedish women. Maturitas 1996; 25: 193-9.
    • (1996) Maturitas , vol.25 , pp. 193-199
    • Hammer, M.1    Brynhildsen Dabrosin, L.2    Frisk, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.